Ligand validation:1WDK

N8E: 3,6,9,12,15-PENTAOXATRICOSAN-1-OL

N8E is a Ligand Of Interest in 1WDK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1WDK_N8E_B_2002	21%	79%	0.247	0.854	0.46	0.4	-	-	1	0	100%	1
1WDK_N8E_A_1002	11%	78%	0.298	0.821	0.46	0.44	-	-	1	0	100%	1
1WDK_N8E_B_2003	7%	78%	0.261	0.707	0.49	0.41	-	-	7	0	100%	1
1WDK_N8E_A_1003	4%	78%	0.359	0.732	0.46	0.44	-	-	6	0	100%	1
1WDL_N8E_A_1003	11%	81%	0.299	0.818	0.4	0.43	-	-	2	0	100%	1
1TV5_N8E_A_1004	48%	74%	0.192	0.934	0.38	0.64	-	-	2	0	100%	1
4AIP_N8E_A_1743	44%	50%	0.16	0.885	0.91	1.01	-	-	4	0	100%	1
2W6U_N8E_A_1817	23%	62%	0.248	0.872	0.8	0.67	-	-	9	0	100%	0.5
7Y9B_N8E_A_302	21%	76%	0.29	0.903	0.49	0.46	-	-	0	0	100%	1
2W76_N8E_A_1817	20%	62%	0.264	0.869	0.71	0.73	-	-	2	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.